What does Ironwood Pharmaceuticals, Inc. do?

Jun 22 2025 06:44 PM IST
share
Share Via
Ironwood Pharmaceuticals, Inc. is a biotechnology company focused on developing products for unmet medical needs. As of March 2025, it reported net sales of $41 million and a net loss of $37 million, with a market cap of $102.69 million.
Overview:
Ironwood Pharmaceuticals, Inc. is a biotechnology company operating in the Pharmaceuticals & Biotechnology industry, focusing on advancing product opportunities in areas of unmet medical need. Financial Snapshot: - Most recent Net Sales: 41 Million (Quarterly Results - Mar 2025) - Most recent Net Profit: -37 Million (Quarterly Results - Mar 2025) - Market cap: USD 102.69 Million (Small Cap) Key Metrics: - P/E: NA (Loss Making) - Industry P/E: NA - Dividend Yield: 0.00% - Debt Equity: -1.43 - Return on Equity: 2.69% - Price to Book: -0.31 Contact Details: - Address: 100 Summer St Ste 2300, BOSTON MA: 02110-2156 - Tel: ['1 617 6217722', '1 617 3745082'] - Fax: 1 617 4940480 - Website: http://www.ironwoodpharma.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News